Skip to main content
Cognition-Enhancing Drugs: Can We Say No?
Faculty Scholarship
  • Frank Pasquale, University of Maryland Francis King Carey School of Law
Document Type
Publication Date
  • arms race,
  • psychopharmaceuticals,
  • drugs,
  • enhancement,
  • emotion
Normative analysis of cognition-enhancing drugs frequently weighs the liberty interests of drug users against egalitarian commitments to a "level playing field." Yet those who would refuse to engage in neuroenhancement may well find their liberty to do so limited in a society where such drugs are widespread. To the extent that unvarnished emotional responses are world-disclosive, neurocosmetic practices also threaten to provide a form of faulty data to their users. This essay examines underappreciated liberty-based and epistemic rationales for regulating cognition-enhancing drugs.
Publication Citation
30 Bulletin of Science, Technology & Society 9 (2010).
Citation Information
30 Bulletin of Science, Technology & Society 9 (2010).